Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Vaccine

• Publication date

  2005-03-07

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/J.VACCINE.2004.11.017PMID 15734055
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conformational analysis of hepatitis B surface antigen fusions in an Agrobacterium-mediated transient expression system.

  2004cited by this paper
• Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato

  2003cited by this paper
• A plant signal peptide–hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells

  2003cited by this paper
• Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies.

  2003cited by this paper
• Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers.

  2003cited by this paper
• Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine.

  2002cited by this paper
• Oral immunization with hepatitis B surface antigen expressed in transgenic plants

  2001cited by this paper
• Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes.

  2000cited by this paper
• Process Options in Hepatitis B Surface Antigen Extraction from Transgenic Potato

  2000cited by this paper
• Biochemical characterization of a smaller form of recombinant Norwalk virus capsids assembled in insect cells

  1997cited by this paper
• Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice.

  1996cited by this paper
• Oral immunization with a recombinant bacterial antigen produced in transgenic plants

  1995cited by this paper
• The structure of hepatitis B envelope and molecular variants of hepatitis B virus

  1995cited by this paper
• Safety and efficacy of a recombinant yeast-derived pre-S2 + S-containing hepatitis B vaccine (TGP-943): phase 1, 2 and 3 clinical testing.

  1994cited by this paper
• Hepatitis B Vaccines in Clinical Practice

  1993cited by this paper
• Hepatitis B Vaccines in Clinical Practice

  1992cited by this paper
• New plant binary vectors with selectable markers located proximal to the left T-DNA border

  1992cited by this paper
• Expression of hepatitis B surface antigen in transgenic plants.

  1992cited by this paper
• Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein

  1992cited by this paper
• Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens.

  1991cited by this paper
• A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.

  1986cited by this paper
• Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen.

  1985cited by this paper
• Synthesis and assembly of hepatitis B virus surface antigen particles in yeast

  1982cited by this paper

• Evaluation of edible vaccines derived from potatoes expressing cholera toxin B subunit as an alternative strategy for immunization

  2026cites this paper
• Plant-based edible vaccines: Can cholera be the case study in Africa?

  2025cites this paper
• Engineering local Kenyan Irish potato varieties as carriers for edible cholera vaccines

  2025cites this paper
• Novel applications of the tomato microbiome: Roles and considerations for agriculture, human health, and society

  2025cites this paper
• Transcriptome Analysis Reveals a Diverse Range of Novel Viruses in Australian Sugarcane Soldier Fly (Inopus flavus) Larvae

  2024cites this paper
• Virus-like Particles Produced in Plants: A Promising Platform for Recombinant Vaccine Development

  2024cites this paper
• Potentiating Virus-like Particles for Mucosal Vaccination Using Material Science Approaches

  2024cites this paper
• Viral protein nanoparticles (Part 1): pharmaceutical characteristics.

  2023cites this paper
• EXAMINATION OF THE TIME DELAYED INDUCTION BETWEEN PRIOR ENCAPSULATION OF CATALYTIC ENZYMES IN P22 VIRUS-LIKE PARTICLES

  2023cites this paper
• Viral protein-based nanoparticles (Part 2): Pharmaceutical applications.

  2023cites this paper
• Virus‐like particles as powerful vaccination strategy against human viruses

  2023cites this paper
• Compendium on Food Crop Plants as a Platform for Pharmaceutical Protein Production

  2022cites this paper
• Can Virus-like Particles Be Used as Synergistic Agent in Pest Management?

  2022cites this paper
• Plant-Based Vaccines: Antigen Design, Diversity, and Strategies for High Level Production

  2022cites this paper
• Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer?

  2021cites this paper
• Plant-based vaccines and cancer therapy: Where are we now and where are we going?

  2021cites this paper
• Hepatitis B core-based virus-like particles: A platform for vaccine development in plants

  2021cites this paper
• Plant-Based Vaccines Against Infectious Human Viral Diseases: Spotlight on HIV Vaccines

  2021cites this paper
• Genetic Engineering Technique in Virus-Like Particle Vaccine Construction

  2021cites this paper
• Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines

  2021cites this paper
• Development and characterization of a plant-derived rotavirus-like particle vaccine.

  2021cites this paper
• Demystifying particle-based oral vaccines

  2021cites this paper
• Oligomerization of IC43 resulted in improved immunogenicity and protective efficacy against Pseudomonas aeruginosa lung infection.

  2020cites this paper
• Plant Virology Delivers Diverse Toolsets for Biotechnology

  2020cites this paper
• Optimization of transfection process to obtain fluorescent Influenza Virus-like particles for drug delivery

  2020cites this paper
• Viruses and Virus-Like Particles in Biotechnology: Fundamentals and Applications

  2019cites this paper
• Viral Diversity, Evolution, and Selective Pressure

  2019cites this paper
• Current and New Approaches for Mucosal Vaccine Delivery

  2019cites this paper
• Plant-made oral vaccines evaluation of capsules 2011

  2019cites this paper
• Applications of Nanoparticles to Deliver Vaccines and Associated Obstacles

  2019cites this paper
• Synthesis of Seed-Specific Bidirectional Promoters for Metabolic Engineering of Anthocyanin-Rich Maize

  2018cites this paper
• 42 – Norovirus Vaccines

  2018cites this paper
• Virus-like particle vaccines: immunology and formulation for clinical translation

  2018cites this paper
• Molecular Pharming: Plant-Made Vaccines

  2018cites this paper
• A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola Virus

  2017cites this paper
• Production of virus-like particles for vaccines

  2017cites this paper
• Chapter 13 – Vaccine Development

  2017cites this paper
• Plant-Made Vaccines in the Fight Against Cancer.

  2017cites this paper
• Plant-made potyvirus-like particles used for log-increasing antibody sensing capacity.

  2017cites this paper
• TIBTEC 1450 No . of Pages 16 Glossary Cancer immunotherapy : a treatment targeting cancer cells

  2017cites this paper
• Plant-expressed Hepatitis B core antigen virus-like particles: Characterization and investigation of their stability in simulated and pig gastro-intestinal fluids.

  2017cites this paper
• Plant-Based Edible Vaccines: Issues and Advantages

  2017cites this paper
• Biomanufacturing of protective antibodies and other therapeutics in edible plant tissues for oral applications

  2016cites this paper
• Infection models of human norovirus: challenges and recent progress

  2016cites this paper
• Formulation and Manufacturing

  2016cites this paper
• Synthesis and assembly of dengue virus envelope protein fused to cholera toxin B subunit into biologically active oligomers in transgenic tomato (Solanum lycopersicum)

  2016cites this paper
• Production of Virus-Like Particles in Plants

  2015cites this paper
• Isolamento e caracterização de proteínas foliares da Ilex paraguariensis St. Hil. (erva mate)

  2015cites this paper
• Global Burden of Norovirus and Prospects for Vaccine Development

  2015cites this paper
• Carrot Cells: A Pioneering Platform for Biopharmaceuticals Production

  2015cites this paper
• Current status of viral expression systems in plants and perspectives for oral vaccines development

  2015cites this paper
• N-Glycosylation Modification of Plant-Derived Virus-Like Particles: An Application in Vaccines

  2014influential citation
• Virus-like particles in picornavirus vaccine development

  2014cites this paper
• Norovirus Narita 104 Virus-Like Particles Expressed in Nicotiana benthamiana Induce Serum and Mucosal Immune Responses

  2014cites this paper
• Plant-based vaccines against viruses

  2014cites this paper
• International Journal for Pharmaceutical Research Scholars (IJPRS)

  2014cites this paper
• Plant-Based Vaccines Against Hepatitis B

  2014cites this paper
• Novel Expression Systems for Vaccine Production

  2014cites this paper
• Viral Vector-Based Expression Strategies

  2014cites this paper
• The Twenty-Year Story of a Plant-Based Vaccine Against Hepatitis B: Stagnation or Promising Prospects?

  2013cites this paper
• An Investigation into the Use of a Plant-Expressed Virus-Like Particle as an Oral Vaccine Candidate

  2013cites this paper
• Stability and inheritance analysis of transgenic Tobacco expressing Hepatitis B surface antigen

  2013cites this paper
• Virus-like particles produced in plants as potential vaccines

  2013cites this paper
• Plant-derived virus-like particles as vaccines

  2013cites this paper
• Recent advances and safety issues of transgenic plant-derived vaccines

  2013cites this paper
• International Journal for Pharmaceutical Research Scholars (IJPRS)

  2013cites this paper
• Transgenic tomato plants expressing the antigen gene PfCP-2.9 of Plasmodium falciparum

  2013cites this paper
• A perspective for atherosclerosis vaccination: is there a place for plant-based vaccines?

  2013cites this paper
• Norovirus replication and attenuation

  2013cites this paper
• Characterization of T 2 Tobacco Plants expressing the Hepatitis B gene for Molecular and Morphological Characters

  2013cites this paper
• Single low-dose un-adjuvanted HBsAg nanoparticle vaccine elicits robust, durable immunity.

  2013cites this paper
• Virus-like Particle Vaccines for Norovirus Gastroenteritis

  2013influential citation
• Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

  2012influential citation
• Research advances in plant-made flavivirus antigens.

  2012cites this paper
• Is an oral plant-based vaccine against hepatitis B virus possible?

  2012cites this paper
• Plant expression, lyophilisation and storage of HBV medium and large surface antigens for a prototype oral vaccine formulation

  2012influential citation
• Molecular determinants of virus-like nanoparticle assembly in vitro and in animal cell culture

  2012cites this paper
• A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose

  2012cites this paper
• Virus-like particles elicit enhanced immunity to influenza and provide the scaffolding for a novel vaccine platform

  2012cites this paper
• Virus‐Like Particle Bioprocessing

  2012cites this paper
• [Current status and industrialization of transgenic tomatoes].

  2011cites this paper
• Biological and Immunological Characterization of Plant-Produced HIV-1 Gag/dgp41 Virus-Like Particles

  2011cites this paper
• Developments in virus-like particle-based vaccines for infectious diseases and cancer

  2011cites this paper
• Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine.

  2011cites this paper
• Progress Towards a Needle-Free Hepatitis B Vaccine

  2011cites this paper
• Viruses and Virus-Like Particles in Biotechnology

  2011cites this paper
• Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches

  2011cites this paper
• Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts

  2011cites this paper
• Overview of expression of hepatitis B surface antigen in transgenic plants.

  2010cites this paper
• Development of plant-based mucosal vaccines against widespread infectious diseases

  2010cites this paper
• Virus-like particles in vaccine development

  2010cites this paper
• Nanogram Doses of Alum-Adjuvanted HBs Antigen Induce Humoral Immune Response in Mice When Orally Administered

  2010cites this paper
• Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulation

  2010cites this paper
• The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza.

  2010cites this paper
• An Intranasally Delivered Toll-Like Receptor 7 Agonist Elicits Robust Systemic and Mucosal Responses to Norwalk Virus-Like Particles

  2010cites this paper
• Antiviral strategies to control calicivirus infections

  2010cites this paper
• Virus-like particles show promise as candidates for new vaccine strategies

  2010cites this paper
• Plant-Produced Biopharmaceuticals

  2010cites this paper
• Variation of Total Soluble Protein Content in Fruit among Six Greenhouse Tomato Cultivars

  2010cites this paper
• Virus-like particles show promise as candidates for new vaccine strategies "The development of new vaccine strategies based on VLPs is certainly a rapidly evolving field. Considering their flexibility, VLPs offer great opportunities of application in vaccinology."

  2010cites this paper